Pectin Intervention Study and Long-term Follow-up in Lipid Transfer Proteins Allergic Patients

ConditionFood Allergy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

About this trial

Pectins are dietary fibers that have shown a health effect on patients with food allergy, as they are capable of modifying the composition of gastrointestinal microbiota, and producing an immunomodulatory effect. Preliminary results by the investigators show that the intervention for 2 months with pectins produces an increase in tolerance to peach, and changes in the microbiota compared to the group of patients treated with placebo. In this project, the investigators aim to study these clinical effects and the involved mechanisms. Moreover, the long-term effect (clinical reactivity to nsLTP and immunomodulatory effect) of the dietary intervention will be prospectively evaluated 6 months after the intervention.

Eligibility criteria

Qualifiers

Adults with a clear clinical history of food allergy after eating peach (oral allergy syndrome and/or systemic symptoms) and with or without clinical history of food allergy with peanut.

Sensitization to Pru p 3 by positive skin prick test (SPT wheal area >7 mm2) and specific IgE (sIgE >0.35 kUA/L)

Positive DBPCFC with peach juice.

If clinical history of food allergy with peanut, sensitization must be confirmed by positive SPT to peanut and sIgE >0.35 kUA/L to Ara h 9 and clinical reactivity through a positive DBPCFC with peanut.

Disqualifiers

Food allergy to corn.

Food allergy to peanut due to sensitization to storage proteins.

Previous/active treatment with sublingual immunotherapy to Pru p 3.

Pregnancy/lactation.

Trial design

Treatments tested in this trial

  • Apple pectin (DE 57%)
  • Placebo

Treatment groups

62 Participants
are divided into 2 treatment groups